IMCD Overview
- Founded
- 1995
- Status
- Public
- Employees
- 2,991
- Stock Symbol
- IMCD
- Investments
- 53
- Share Price
- $122.86
- (As of Friday Closing)
IMCD General Information
Description
IMCD NV manufactures and sells a variety of chemicals and food ingredients. The firm's product portfolio consists of two major categories: life sciences and industrials. Life sciences products include pharmaceuticals, personal-care products, and food and nutrition additives and ingredients. Industrials products include coatings, lubricants, synthesis chemicals, plastics, and detergents for home and commercial use. The company organizes itself into four primary segments based on geography: Europe, Asia-Pacific, other emerging markets, and United States. Most of IMCD's revenue comes from Europe.
Contact Information
Website
Formerly Known As
Internatio, Internatio-Muller (Chemical Distribution)
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Holding Companies
Other Industries
Specialty Chemicals
Other Commercial Products
Stock Exchange
AMS
Primary Office
- P.O. Box 5802
- 3008 AV Rotterdam
- Netherlands
+31 010 000 0000
IMCD Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $122.86 | $121.72 | $56.61 - $131.11 | $6.99B | 56.9M | 146K | $2.27 |
IMCD Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 5,478,989 | 5,038,846 | 3,827,954 | 3,647,811 |
| Revenue | 2,988,364 | 3,010,888 | 2,807,495 | 2,151,046 |
| EBITDA | 269,688 | 267,764 | 241,994 | 182,349 |
| Net Income | 119,205 | 120,907 | 118,074 | 87,133 |
| Total Assets | 2,468,068 | 2,450,809 | 2,229,843 | 1,984,597 |
| Total Debt | 635,746 | 657,107 | 551,020 | 441,245 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
IMCD Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore IMCD‘s full profile, request access.
Request a free trialIMCD Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
IMCD NV manufactures and sells a variety of chemicals and food ingredients. The firm's product portfolio consists of two
Holding Companies
Rotterdam, Netherlands
2,991
As of 2019
00000
0.000
0000-00-00
00000000000
00000
00000000
t dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut al
00000-0000 000000000
Essen, Germany
00000
As of 0000
00000
00000000000
00000
0000000
it amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna ali
000000000 000000000
Chicago, IL
000
As of 0000
00000
000000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialIMCD Competitors (7)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Brenntag | Formerly PE-Backed | Essen, Germany | 00000 | 00000 | 00000000000 | 00000 |
| 0000000 000000000 | Private Equity-Backed | Chicago, IL | 000 | 00000 | 000000000 | 00000 |
| 000000 | Corporate Backed or Acquired | Rotterdam, Netherlands | 000 | 000000&0 | ||
| 00000000 | Private Equity-Backed | Harleysville, PA | 0000 | 000000000000 | ||
| 000 000000000 | Corporate Backed or Acquired | Fort Worth, TX | 000 | 00000 | 000000&0 | 00000 |
IMCD Executive Team (20)
IMCD Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 00000 | Self | Vice Chairman & Chairman, Audit Committee | 000 0000 |
| 0. 000000000 | IMCD | Member Of Supervisory Board | 000 0000 |
| 0. 000 00000 00000 | IMCD | Board Member | 000 0000 |
| 0000-0000000 00000 | Self | Board Member | 000 0000 |
IMCD Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialIMCD Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore IMCD‘s full profile, request access.
Request a free trialIMCD Investments & Acquisitions (53)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 00000 (00000 | 26-Nov-2020 | 000000000000000000 | Distributors/Wholesale | 00000 000000 | |
| 0000 0000000000000 | 05-Nov-2020 | 000000000000000000 | Pharmaceuticals | 00000000 0000000 | |
| 000000 0000000000 | 04-Nov-2020 | 000000000000000000 | Distributors (Healthcare) | 0000 000 000 000000 | |
| 00000-00000 | 18-Sep-2020 | 000000000000000000 | Distributors/Wholesale | 0000 0000000 | |
| Siyeza Fine Chem | 01-Sep-2020 | Merger/Acquisition | Other Healthcare Services |
IMCD Subsidiaries (17)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Network Nutrition | Biotechnology | Sydney, Australia | 2004 |
| 00000 00000000 000 | Multi-line Chemicals | Mumbai, India | 0000 |
| 000000000 | Distributors/Wholesale | Milan, Italy | 0000 |
| 000000 00000000000 | Distributors (Healthcare) | Seoul, South Korea | 0000 |
| 000 000000 | Pharmaceuticals | Basel, Switzerland | 0000 |
IMCD Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000000 | 12-Nov-2012 | 0000000000 | Completed |
|